Altimmune Newsroom

Altimmune Analyst Ratings

BenzingaAug 12 14:44 ET

Buy Rating on Altimmune: Pemvidutide's Market Potential in Obesity and Beyond

TipRanksAug 12 12:42 ET

Evercore ISI Remains a Buy on Altimmune (ALT)

TipRanksAug 9 09:55 ET

Buy Rating Affirmed for Altimmune as Pemvidutide Poised to Lead NASH Treatment Market

TipRanksAug 8 18:00 ET

B.Riley Financial Maintains Altimmune(ALT.US) With Buy Rating, Announces Target Price $20

Moomoo NewsAug 2 07:31 ET

Altimmune Analyst Ratings

BenzingaJun 21 13:52 ET

Buy Rating Affirmed for Altimmune on Promising Pemvidutide Data and Market Position

TipRanksMay 30 02:09 ET

Buy Rating Justified by Altimmune's Promising Pemvidutide Efficacy in NASH Treatment

TipRanksMay 21 18:10 ET

Altimmune Analyst Ratings

BenzingaMay 14 07:52 ET

Buy Rating Justified: Altimmune's Pemvidutide Shows Best-in-Class Potential for Obesity and MASH

TipRanksMay 14 06:25 ET

Buy Rating Affirmed for Altimmune on Pemvidutide's Potential and Strategic Advancements

TipRanksMay 10 14:30 ET

Altimmune Analyst Ratings

BenzingaMay 10 12:37 ET

Analysts Offer Insights on Healthcare Companies: Altimmune (ALT), Evolent Health (EVH) and Cormedix (CRMD)

TipRanksMay 10 01:15 ET

Altimmune Analyst Ratings

BenzingaApr 29 06:42 ET

Analysts Offer Insights on Healthcare Companies: Roivant Sciences (ROIV), Terns Pharmaceuticals (TERN) and Altimmune (ALT)

TipRanksApr 3 08:15 ET

Altimmune Analyst Ratings

BenzingaApr 1 12:24 ET

Altimmune's Pemvidutide Shows Promise for Obesity Treatment, Justifying Buy Rating

TipRanksApr 1 12:20 ET

Altimmune Analyst Ratings

BenzingaMar 28 11:57 ET

Analysts Are Bullish on Top Healthcare Stocks: Moderna (MRNA), Altimmune (ALT)

TipRanksMar 28 08:07 ET

Analysts Offer Insights on Healthcare Companies: Altimmune (ALT), Kiora Pharmaceuticals (KPRX) and Actinium Pharmaceuticals (ATNM)

TipRanksMar 28 07:35 ET